← Open Payments lookup

KEVIN O'SULLIVAN: Open Payments

NPI 1922492859 · TEXARKANA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$967 in 32 payments from 16 companies in 2025. Trend: 2023 $1,274 · 2024 $910 · 2025 $967

Food & beverage: $967
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$176
ABBVIE INC.3$156
EVOKE PHARMA, INC.1$100
Novo Nordisk Inc2$99
Abbott Laboratories1$78
Amgen Inc.4$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
Phathom Pharmaceuticals, Inc.1$46
PFIZER INC.2$40
Exact Sciences Corporation2$33

Products named: FARXIGA, VRAYLAR, GIMOTI, Ozempic, FREESTYLE LIBRE 3, OTEZLA, CAPLYTA, VOQUEZNA.

Industry payments across AR — which companies pay providers there.